相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
Daniela Alterio et al.
ACTA ONCOLOGICA (2020)
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
Catherine de Martel et al.
LANCET GLOBAL HEALTH (2020)
Network-meta-analysis of chemotherapy in nasopharyngeal carcinoma (MAC-NPC): An update on 8,221 patients.
Claire Petit et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
E. P. Hui et al.
ANNALS OF ONCOLOGY (2020)
NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma
Anne W. M. Lee et al.
CANCER (2020)
Clinical Outcome-Related Mutational Signatures Identified by Integrative Genomic Analysis in Nasopharyngeal Carcinoma
Wei Dai et al.
CLINICAL CANCER RESEARCH (2020)
An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach
Guan-Qun Zhou et al.
NATURE COMMUNICATIONS (2020)
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
Nicola Alessandro Iacovelli et al.
FRONTIERS IN ONCOLOGY (2020)
Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma
A. D. King et al.
ANNALS OF ONCOLOGY (2019)
Boost in proton for locally advanced nasopharyngeal carcinoma: A Curie Institute experience
A. Beddok et al.
CANCER RADIOTHERAPIE (2019)
Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study
Chong Zhao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W. Lee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The racial disparity of nasopharyngeal carcinoma based on the database analysis
Lei Zhou et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2019)
Clinical value of a plasma Epstein-Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis
Haiqin Peng et al.
BIOSCIENCE REPORTS (2019)
Management of locally recurrent nasopharyngeal carcinoma
Anne W. M. Leea et al.
CANCER TREATMENT REVIEWS (2019)
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
Qi Yang et al.
EUROPEAN JOURNAL OF CANCER (2019)
1108OChemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma: A randomized, open-label, phase III trial
M Chen et al.
ANNALS OF ONCOLOGY (2019)
Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
Cheng Xu et al.
FRONTIERS IN ONCOLOGY (2019)
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma
Rui Guo et al.
CANCER (2019)
The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up
San-Gang Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Salvage Treatment Using Carbon Ion Radiation in Patients With Locoregionally Recurrent Nasopharyngeal Carcinoma: Initial Results
Jiyi Hu et al.
CANCER (2018)
Facility Volume and Survival in Nasopharyngeal Carcinoma
Emi J. Yoshida et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy
Lachlan J. McDowell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Anthony T. C. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
Lin-Quan Tang et al.
LANCET ONCOLOGY (2018)
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study
Xin-Ran Tang et al.
LANCET ONCOLOGY (2018)
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
K. H. Au et al.
ORAL ONCOLOGY (2018)
Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: Based on hazard-rate and patterns of recurrence
Tingting Xu et al.
ORAL ONCOLOGY (2018)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W. Lee et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
Hongru Yang et al.
RADIOTHERAPY AND ONCOLOGY (2018)
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma
Chawalit Lertbutsayanukul et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival
Hong Li et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Human Papillomavirus and World Health Organization Type III Nasopharyngeal Carcinoma: Multicenter Study From an Endemic Area in Southern China
Wen Bo Huang et al.
CANCER (2018)
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
Jie Lin et al.
ONCOTARGET (2017)
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline
Larissa Nekhlyudov et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Proton therapy for head and neck cancer: expanding the therapeutic window
Jonathan E. Leeman et al.
LANCET ONCOLOGY (2017)
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K. C. Allen Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Delayed clinical complete response to intensity-modulated radiotherapy in nasopharyngeal carcinoma
Wen-Fei Li et al.
ORAL ONCOLOGY (2017)
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area
Salvatore Alfieri et al.
ONCOTARGET (2017)
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis
Rui You et al.
THERANOSTICS (2017)
Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review
A. Prawira et al.
BRITISH JOURNAL OF CANCER (2017)
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity
Anne W. M. Lee et al.
CANCER (2017)
Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy
Tai-Lin Huang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes
Gary D. Lewis et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
Lin-Quan Tang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma
Lin-Quan Tang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Global trends in incidence and mortality of nasopharyngeal carcinoma
Ling-Ling Tang et al.
CANCER LETTERS (2016)
Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival
Yun-hong Tian et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Li Zhang et al.
LANCET (2016)
Comparison of (18)F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis
Junbao Wei et al.
ORAL ONCOLOGY (2016)
Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors
Alan Kiang et al.
RADIATION ONCOLOGY (2016)
The significant survival advantage of female sex in nasopharyngeal carcinoma: a propensity-matched analysis
P-Y OuYang et al.
BRITISH JOURNAL OF CANCER (2015)
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
Gemma Gatta et al.
EUROPEAN JOURNAL OF CANCER (2015)
Nasopharyngeal Cancer: Molecular Landscape
Jeff P. Bruce et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard et al.
LANCET ONCOLOGY (2015)
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
Binglan Zhang et al.
ORAL ONCOLOGY (2015)
Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison
Rui You et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Outcome of Patients Undergoing Salvage Surgery for Recurrent Nasopharyngeal Carcinoma: A Meta-analysis
Shorook Na'ara et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
Y-M Tian et al.
BRITISH JOURNAL OF CANCER (2014)
Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors
L. Zeng et al.
BRITISH JOURNAL OF CANCER (2014)
The Role of Plasma Epstein-Barr Virus DNA in the Management of Recurrent Nasopharyngeal Carcinoma
Jimmy Yu Wai Chan et al.
LARYNGOSCOPE (2014)
The genomic landscape of nasopharyngeal carcinoma
De-Chen Lin et al.
NATURE GENETICS (2014)
Etiological factors of nasopharyngeal carcinoma
Sai Wah Tsao et al.
ORAL ONCOLOGY (2014)
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
Vincent Gregoire et al.
RADIOTHERAPY AND ONCOLOGY (2014)
A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma
Jin-Gao Li et al.
CANCER (2013)
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
Quynh-Thu Le et al.
CLINICAL CANCER RESEARCH (2013)
Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: A systematic review and meta-analysis
Ming-Che Chang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy
Yi-Jun Hua et al.
EUROPEAN JOURNAL OF CANCER (2012)
Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma
Cheng-Lung Hsu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
Lei Chen et al.
LANCET ONCOLOGY (2012)
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
Nancy Y. Lee et al.
LANCET ONCOLOGY (2012)
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
Na Liu et al.
LANCET ONCOLOGY (2012)
A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma
Pei-Yu Huang et al.
ORAL ONCOLOGY (2012)
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Herbert H. Loong et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000-2011 Rosetta Stone for NPC: Genetics, viral infection, and other environmental factors
Allan Hildesheim et al.
SEMINARS IN CANCER BIOLOGY (2012)
CLINICAL OUTCOMES AND PATTERNS OF FAILURE AFTER INTENSITY-MODULATED RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA
Wai Tong Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
HOW DOES INTENSITY-MODULATED RADIOTHERAPY VERSUS CONVENTIONAL TWO-DIMENSIONAL RADIOTHERAPY INFLUENCE THE TREATMENT RESULTS IN NASOPHARYNGEAL CARCINOMA PATIENTS?
Shu-Zhen Lai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Eight-Signature Classifier for Prediction of Nasopharnyngeal Carcinoma Survival
Hai-Yun Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
Qiu-Yan Chen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Pretreatment Quality of Life As a Predictor of Distant Metastasis and Survival for Patients With Nasopharyngeal Carcinoma
Fu-Min Fang et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority open trial
Imjai Chitapanarux et al.
EUROPEAN JOURNAL OF CANCER (2007)
Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma
DLW Kwong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
P Comoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
ATC Chan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes
KCM Straathof et al.
BLOOD (2005)
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
JC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
CT-based delineation of lymph node levels and related CTVs in the node-negative neck:: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines
V Grégoire et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type
A Fandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
